Form D · Biotechnology
MICROMED CARDIOVASCULAR INC
Houston, TX · CIK 0001269515
Offering snapshot reported Dec 13, 2011 · SEC filing
- Reported sold
- $3.19M Offering amount: $10M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Nov 16, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 13, 2011 | Initial | $3,185,680 | No comparison | 0 | SEC filing |
| Sep 15, 2011 | Initial | $3,752,323 | No comparison | 0 | SEC filing |
| Apr 6, 2011 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jan 31, 2011 | Initial | $4,083,500 | No comparison | 37 | SEC filing |
| Oct 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $167K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-169996
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Hobart McKinley Birmingham Jr. | 5026583 | GBS Financial Corp · CRD 16906 |
Source: Form D, filed Dec 13, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joel Barnes Alvord | Director |
| Raymond Bernal | Director |
| William Manning Birdsall | Director, Executive |
| Hobart Mc Kinley Birmingham, Jr. | Promoter |
| Hobart Mc Kinley Brimingham, Jr. | Promoter |
| William Luby Burke | Promoter |
| Roger Gilbert Ford | Director |
| Rodger Gilbert Ford | Director |
| Mark Charles Goldberg | Director |
| Norwick Beauford Huston Goodspeed | Director |
| Jay Jeffrey Kraemer | Executive |
| Bryan Edwin Lynch | Executive |
| John David Mackstaller | Director, Executive |
| Sailesh Raj Saxena | Executive |
| Marvin Jacob Slepian | Director |
| Anthony Wayne Williams | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8965 Interchange Drive
Houston, TX, 77054
Houston, TX, 77054